questionsmedicales.fr
Bactéries
Proteobacteria
Gammaproteobacteria
Vibrionaceae
Vibrio
Vibrio cholerae
Vibrio cholerae : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Choléra
Diagnostic microbiologique
Tests de diagnostic
Vibrio cholerae
Période d'incubation
Choléra
Symptômes
5
Choléra
Portage asymptomatique
Traitements
5
Traitement du choléra
Réhydratation
Efficacité du traitement
Choléra
Facteurs de risque
5
Facteurs de risque
Choléra
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae : Questions médicales les plus fréquentes",
"headline": "Vibrio cholerae : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vibrio cholerae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-28",
"dateModified": "2025-04-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Vibrio",
"url": "https://questionsmedicales.fr/mesh/D014733",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio",
"code": {
"@type": "MedicalCode",
"code": "D014733",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae non-O1",
"alternateName": "Vibrio cholerae non-O1",
"url": "https://questionsmedicales.fr/mesh/D044163",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae non-O1",
"code": {
"@type": "MedicalCode",
"code": "D044163",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.075"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O1",
"alternateName": "Vibrio cholerae O1",
"url": "https://questionsmedicales.fr/mesh/D041241",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O1",
"code": {
"@type": "MedicalCode",
"code": "D041241",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.151"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O139",
"alternateName": "Vibrio cholerae O139",
"url": "https://questionsmedicales.fr/mesh/D041242",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O139",
"code": {
"@type": "MedicalCode",
"code": "D041242",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.200"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae",
"alternateName": "Vibrio cholerae",
"code": {
"@type": "MedicalCode",
"code": "D014734",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Firdausi Qadri",
"url": "https://questionsmedicales.fr/author/Firdausi%20Qadri",
"affiliation": {
"@type": "Organization",
"name": "Infectious Diseases Division, icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh."
}
},
{
"@type": "Person",
"name": "Munirul Alam",
"url": "https://questionsmedicales.fr/author/Munirul%20Alam",
"affiliation": {
"@type": "Organization",
"name": "International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh."
}
},
{
"@type": "Person",
"name": "Shanta Dutta",
"url": "https://questionsmedicales.fr/author/Shanta%20Dutta",
"affiliation": {
"@type": "Organization",
"name": "National Institute of Cholera and Enteric Diseases, NICED-JICA Building, 57 Dr. S.C. Banerjee Road, Beliaghata, Kolkata, 700 010, India."
}
},
{
"@type": "Person",
"name": "Shelley M Payne",
"url": "https://questionsmedicales.fr/author/Shelley%20M%20Payne",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Biosciences and LaMontagne Center for Infectious Diseases, The University of Texas at Austin, Austin, Texas, USA payne@utexas.edu."
}
},
{
"@type": "Person",
"name": "Bibhuti Bhusan Pal",
"url": "https://questionsmedicales.fr/author/Bibhuti%20Bhusan%20Pal",
"affiliation": {
"@type": "Organization",
"name": "Microbiology Division, ICMR-Regional Medical Research Centre, Chandrasekharpur, Bhubaneswar, 751023, Orissa, India. Electronic address: bbpal_rmrc@yahoo.co.in."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Clindamycin-Benzoyl Peroxide Gel Compared with Clindamycin Lotion for Hidradenitis Suppurativa: A Randomized Controlled Assessor-Blinded Intra-Patient Pilot Study.",
"datePublished": "2023-04-20",
"url": "https://questionsmedicales.fr/article/37080176",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000530758"
}
},
{
"@type": "ScholarlyArticle",
"name": "Acute paronychia in a neonate secondary to clindamycin-resistant Staphylococcus aureus.",
"datePublished": "2022-09-01",
"url": "https://questionsmedicales.fr/article/36047838",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/pde.15017"
}
},
{
"@type": "ScholarlyArticle",
"name": "Group B streptococcus in the Northern Territory in 2023: clindamycin down but not out.",
"datePublished": "2023-09-21",
"url": "https://questionsmedicales.fr/article/37817335",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.33321/cdi.2023.47.52"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pharmacokinetic interaction between rifampicin and clindamycin in staphylococcal osteoarticular infections.",
"datePublished": "2023-06-10",
"url": "https://questionsmedicales.fr/article/37302771",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijantimicag.2023.106885"
}
},
{
"@type": "ScholarlyArticle",
"name": "Molecular-scale insights into confined clindamycin in nanoscale pores of mesoporous silica.",
"datePublished": "2023-10-18",
"url": "https://questionsmedicales.fr/article/37800330",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/d3cp02596a"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Bactéries",
"item": "https://questionsmedicales.fr/mesh/D001419"
},
{
"@type": "ListItem",
"position": 3,
"name": "Proteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020560"
},
{
"@type": "ListItem",
"position": 4,
"name": "Gammaproteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020563"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vibrionaceae",
"item": "https://questionsmedicales.fr/mesh/D014737"
},
{
"@type": "ListItem",
"position": 6,
"name": "Vibrio",
"item": "https://questionsmedicales.fr/mesh/D014733"
},
{
"@type": "ListItem",
"position": 7,
"name": "Vibrio cholerae",
"item": "https://questionsmedicales.fr/mesh/D014734"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vibrio cholerae - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vibrio cholerae",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vibrio cholerae",
"description": "Comment diagnostiquer une infection par Vibrio cholerae ?\nQuels tests sont utilisés pour confirmer le choléra ?\nQuels symptômes indiquent une infection par Vibrio cholerae ?\nQuelle est la période d'incubation du choléra ?\nComment différencier le choléra d'autres diarrhées ?",
"url": "https://questionsmedicales.fr/mesh/D014734?mesh_terms=Clindamycin#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vibrio cholerae",
"description": "Quels sont les principaux symptômes du choléra ?\nComment se manifeste la déshydratation dans le choléra ?\nLe choléra peut-il être asymptomatique ?\nQuels signes indiquent une déshydratation sévère ?\nLes symptômes du choléra apparaissent-ils rapidement ?",
"url": "https://questionsmedicales.fr/mesh/D014734?mesh_terms=Clindamycin#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vibrio cholerae",
"description": "Comment prévenir l'infection par Vibrio cholerae ?\nLa vaccination contre le choléra est-elle efficace ?\nQuelles mesures d'hygiène sont recommandées ?\nComment l'eau potable peut-elle prévenir le choléra ?\nLes voyages dans des zones à risque nécessitent-ils des précautions ?",
"url": "https://questionsmedicales.fr/mesh/D014734?mesh_terms=Clindamycin#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vibrio cholerae",
"description": "Quel est le traitement principal du choléra ?\nLes antibiotiques sont-ils nécessaires pour le choléra ?\nComment prévenir la déshydratation dans le choléra ?\nQuels médicaments sont utilisés pour traiter le choléra ?\nLe traitement du choléra est-il efficace ?",
"url": "https://questionsmedicales.fr/mesh/D014734?mesh_terms=Clindamycin#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vibrio cholerae",
"description": "Quelles sont les complications possibles du choléra ?\nLe choléra peut-il entraîner la mort ?\nComment la déshydratation affecte-t-elle le corps ?\nQuelles sont les conséquences à long terme du choléra ?\nLe choléra peut-il causer des épidémies ?",
"url": "https://questionsmedicales.fr/mesh/D014734?mesh_terms=Clindamycin#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vibrio cholerae",
"description": "Quels sont les facteurs de risque du choléra ?\nLes enfants sont-ils plus à risque de choléra ?\nComment la malnutrition influence-t-elle le choléra ?\nLes personnes vivant dans des zones urbaines sont-elles à risque ?\nLes voyageurs peuvent-ils être exposés au choléra ?",
"url": "https://questionsmedicales.fr/mesh/D014734?mesh_terms=Clindamycin#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par Vibrio cholerae ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par culture de selles ou tests PCR pour détecter la bactérie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer le choléra ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de culture des selles et les tests rapides de détection d'antigènes sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection par Vibrio cholerae ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent diarrhée aqueuse, vomissements et déshydratation rapide."
}
},
{
"@type": "Question",
"name": "Quelle est la période d'incubation du choléra ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La période d'incubation est généralement de 1 à 5 jours après l'exposition."
}
},
{
"@type": "Question",
"name": "Comment différencier le choléra d'autres diarrhées ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le choléra se caractérise par une diarrhée aqueuse profuse et une déshydratation rapide."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux symptômes du choléra ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux symptômes sont diarrhée aqueuse, vomissements, crampes abdominales."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la déshydratation dans le choléra ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La déshydratation se manifeste par soif intense, sécheresse de la peau et fatigue."
}
},
{
"@type": "Question",
"name": "Le choléra peut-il être asymptomatique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent être porteuses sans présenter de symptômes."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une déshydratation sévère ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent confusion, tachycardie, hypotension et urines très rares."
}
},
{
"@type": "Question",
"name": "Les symptômes du choléra apparaissent-ils rapidement ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent apparaître rapidement, souvent dans les 24 heures."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection par Vibrio cholerae ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'accès à l'eau potable, l'hygiène et la vaccination."
}
},
{
"@type": "Question",
"name": "La vaccination contre le choléra est-elle efficace ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins peuvent réduire le risque d'infection, surtout en zones à risque."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains fréquemment et consommer des aliments bien cuits sont essentiels."
}
},
{
"@type": "Question",
"name": "Comment l'eau potable peut-elle prévenir le choléra ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'eau potable et propre empêche l'ingestion de Vibrio cholerae, réduisant le risque."
}
},
{
"@type": "Question",
"name": "Les voyages dans des zones à risque nécessitent-ils des précautions ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est conseillé de se faire vacciner et de suivre des mesures d'hygiène strictes."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal du choléra ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est la réhydratation orale ou intraveineuse selon la gravité."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils nécessaires pour le choléra ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques peuvent être utilisés pour réduire la durée de la diarrhée et la gravité."
}
},
{
"@type": "Question",
"name": "Comment prévenir la déshydratation dans le choléra ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réhydratation rapide avec des solutions de réhydratation orale est essentielle."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour traiter le choléra ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques comme la doxycycline ou l'azithromycine sont souvent prescrits."
}
},
{
"@type": "Question",
"name": "Le traitement du choléra est-il efficace ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un traitement rapide et approprié est très efficace pour réduire la mortalité."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du choléra ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent déshydratation sévère, choc hypovolémique et insuffisance rénale."
}
},
{
"@type": "Question",
"name": "Le choléra peut-il entraîner la mort ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement rapide, le choléra peut être mortel en raison de la déshydratation."
}
},
{
"@type": "Question",
"name": "Comment la déshydratation affecte-t-elle le corps ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La déshydratation peut entraîner des déséquilibres électrolytiques et des défaillances organiques."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences à long terme du choléra ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les conséquences peuvent inclure des problèmes de santé persistants, comme des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Le choléra peut-il causer des épidémies ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le choléra peut provoquer des épidémies, surtout dans des conditions d'hygiène précaires."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du choléra ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'accès limité à l'eau potable, la malnutrition et l'absence d'hygiène."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque de choléra ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants et les personnes âgées sont plus vulnérables aux complications du choléra."
}
},
{
"@type": "Question",
"name": "Comment la malnutrition influence-t-elle le choléra ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "La malnutrition affaiblit le système immunitaire, augmentant le risque d'infection par choléra."
}
},
{
"@type": "Question",
"name": "Les personnes vivant dans des zones urbaines sont-elles à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les zones urbaines surpeuplées avec un accès limité à l'eau potable sont à risque."
}
},
{
"@type": "Question",
"name": "Les voyageurs peuvent-ils être exposés au choléra ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyageurs dans des régions endommagées par le choléra doivent prendre des précautions."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 22/04/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Infectious Diseases Division, icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh.
Publications dans "Vibrio cholerae" :
5 publications dans cette catégorie
Affiliations :
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Publications dans "Vibrio cholerae" :
5 publications dans cette catégorie
Affiliations :
National Institute of Cholera and Enteric Diseases, NICED-JICA Building, 57 Dr. S.C. Banerjee Road, Beliaghata, Kolkata, 700 010, India.
Publications dans "Vibrio cholerae" :
4 publications dans cette catégorie
Affiliations :
Department of Molecular Biosciences and LaMontagne Center for Infectious Diseases, The University of Texas at Austin, Austin, Texas, USA payne@utexas.edu.
Publications dans "Vibrio cholerae" :
4 publications dans cette catégorie
Affiliations :
Microbiology Division, ICMR-Regional Medical Research Centre, Chandrasekharpur, Bhubaneswar, 751023, Orissa, India. Electronic address: bbpal_rmrc@yahoo.co.in.
Publications dans "Vibrio cholerae" :
4 publications dans cette catégorie
Affiliations :
Microbiology Division, ICMR-Regional Medical Research Centre, Chandrasekharpur, Bhubaneswar, 751023, Orissa, India. Electronic address: smruti2007rkl@gmail.com.
Publications dans "Vibrio cholerae" :
4 publications dans cette catégorie
Affiliations :
Molecular Genetics Laboratory, Centre for Human Microbial Ecology, Translational Health Science and Technology Institute, NCR Biotech Science Cluster, Faridabad 121001, India; School of Life Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India. Electronic address: bhabatosh@thsti.res.in.
Publications dans "Vibrio cholerae" :
4 publications dans cette catégorie
Affiliations :
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Publications dans "Vibrio cholerae" :
4 publications dans cette catégorie
Affiliations :
National Institute of Cholera and Enteric Diseases, NICED-JICA Building, 57 Dr. S.C. Banerjee Road, Beliaghata, Kolkata, 700 010, India.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Maryland Pathogen Research Institute, University of Maryland, College Park, MD, 20742, USA.
Institute for Advanced Computer Studies, University of Maryland, University of Maryland, College Park, MD, 20742, USA.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Division of Global Health, Massachusetts General Hospital for Children, Boston, Massachusetts, USA.
Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Infectious diseases division, icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Infectious diseases division, icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Microbiology Division, ICMR-Regional Medical Research Centre, India.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA; Department of Microbiology, Harvard Medical School, Boston, MA, USA; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, MA, USA; Howard Hughes Medical Institute, Bethesda, MD, USA. Electronic address: mwaldor@research.bwh.harvard.edu.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
National Institute of Cholera and Enteric Diseases, NICED-JICA Building, 57 Dr. S.C. Banerjee Road, Beliaghata, Kolkata, 700 010, India.
Publications dans "Vibrio cholerae" :
3 publications dans cette catégorie
Affiliations :
Graduate School of Medicine, Dentistry and Pharmaceutical Sciences of Okayama University, 1-1-1 Tsushima-naka, Kita-ku, Okayama, Okayama, 700-8530, Japan. Electronic address: k-oka@xd6.so-net.ne.jp.
Publications dans "Vibrio cholerae" :
2 publications dans cette catégorie
Affiliations :
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh.
Publications dans "Vibrio cholerae" :
Antibiotic resistance is a major concern, especially in hidradenitis suppurativa (HS). However, antibiotics form a cornerstone in its treatment. Topical clindamycin is known to cause bacterial resista...
This is a randomized, controlled, assessor-blinded, intra-patient pilot trial to compare the clinical efficacy of clindamycin-benzoyl peroxide gel with clindamycin lotion in patients with mild to mode...
Ten patients were included, resulting in two groups of 10 treated body sites. No significant differences were found between the two groups for all measurements after 12 or 16 weeks, while both therapi...
Clindamycin-benzoyl peroxide gel showed favorable clinical efficacy results, similar to clindamycin lotion, suggesting that it could replace clindamycin lotion in the treatment of mild to moderate HS ...
Paronychia is a common inflammatory condition of the nail fold that is often associated with infection. Causes can be fungal, viral, or most commonly, bacterial. Neonatal paronychia is a rare presenta...
Group B streptococcus (GBS) is a significant cause of perinatal morbidity and mortality; prophylactic antibiotics in the obstetric population can mitigate the risk of neonatal infection. The antibioti...
Oral combination of clindamycin and rifampicin is relevant for the treatment of staphylococcal osteoarticular infection (SOAIs). However, rifampicin induces CYP3A4, suggesting a pharmacokinetic intera...
Patients with SOAI were included. After initial intravenous antistaphylococcal treatment, oral therapy was started with clindamycin (600 or 750 mg t.i.d.), followed by addition of rifampicin 36 h late...
In 19 patients, clindamycin median (range) trough concentrations were 2.7 (0.3-8.9) mg/L and <0.05 (<0.05-0.3) mg/L before and during rifampicin administration, respectively. Rifampicin co-administrat...
Rifampicin co-administration with clindamycin has a high impact on clindamycin exposure and PK/PD targets in SOAI, which could result in clinical failure even for fully susceptible strains....
Clindamycin is an antibiotic used to treat a variety of bacterial infections. The sustained release of clindamycin from the drug carrier is an important strategy to prolong the effective antibacterial...
The goal of this study was to assess the acceptability of a single-dose bioadhesive 2% clindamycin vaginal gel for bacterial vaginosis (BV)....
This double-blind, placebo-controlled, randomized study compared a new clindamycin gel with placebo gel (2:1 ratio). The primary objective was efficacy; secondary objectives were safety and acceptabil...
A total of 307 women with BV were randomized to treatment (204 to the clindamycin gel group and 103 to the placebo gel group). Most (88.3%) reported at least one previously diagnosed BV episode, and m...
A single dose of a new bioadhesive 2% clindamycin vaginal gel showed rapid resolution of symptoms and was highly acceptable as a treatment for bacterial vaginosis....
gov identifier: NCT04370548....
We investigated adverse events in patients with prosthetic joint infections receiving combination therapy with linezolid, rifampicin, and clindamycin for ≥ 7 days. Twenty-two patients were evaluated. ...
A 61-year-old African-American female with moderately controlled Hailey-Hailey disease (HHD) presents to the emergency department with a rash and fever. One day prior to her presentation, she was star...
Patients mislabeled with a penicillin allergy are often unnecessarily given prophylactic clindamycin. Thus, otolaryngologists may cause harm due to clindamycin's associated risk of Clostridioides diff...
A break-even analysis was performed using the average cost of penicillin allergy testing and a CDI/SSI to calculate the absolute risk reduction (ARR) in baseline CDI/SSI rate due to clindamycin requir...
Preoperative penicillin testing was found to be economically sustainable if it could decrease the baseline CDI rate by an ARR of 1.06% or decrease the baseline SSI rate by an ARR of 1.34%. The probabi...
In patients mislabeled with a penicillin allergy, preoperative penicillin allergy testing may be an economically sustainable option to prevent the unnecessary use of prophylactic clindamycin during ot...
NA Laryngoscope, 133:1086-1091, 2023....
As an essential source of the natural dissolved organic matter (DOM), dissolved black carbon (DBC) plays a vital role in the photodegradation of organics; however, there is rare information about the ...